Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro
Background/Aims: Psoralen and bakuchiol are the main active compounds found in the traditional Chinese medicine Psoralea corylifolia L., and have been used to treat osteoporosis. This study aims to investigate the anti-osteoporosis effects of these two compounds using osteoclasts precursor different...
Main Authors: | Lijuan Chai, Kun Zhou, Shaoxia Wang, Han Zhang, Na Fan, Jie Li, Xiaofeng Tan, Limin Hu, Xiang Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-08-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/492554 |
Similar Items
-
ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
by: Xinyue Liang, et al.
Published: (2021-07-01) -
Wheat seedling extract and its constituents attenuate RANKL-induced differentiation and fusion of osteoclasts and bone resorption
by: HanGyeol Lee, et al.
Published: (2023-09-01) -
Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01) -
The effects of seeding density and osteoclastic supplement concentration on osteoclastic differentiation and resorption
by: Stefan J.A. Remmers, et al.
Published: (2023-06-01) -
Comparative efficacy of bakuchiol oil and encapsulated bakuchiol cream on facial skin quality: A 28-day pilot study
by: Mediana Hadiwidjaja, et al.
Published: (2024-05-01)